![]() |
市场调查报告书
商品编码
1635543
全球硬膜替代物市场 - 市场规模(依细分市场)、占有率、监管、偿付、治疗、预测(~2036年)Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
本报告对全球硬膜替代物市场进行了深入分析,提供了依地区划分的市场规模、主要趋势、创新产品和技术以及竞争格局的资讯。
市场模型的主要组成如下:
已上市的硬膜替代物和不断变化的竞争格局
全球、区域和国家层面的市场洞察
掌握包括医疗保健系统概况在内的真实全局,加深对市场的了解。此外,市场进入部分提供有关偿付政策和监管环境的资讯,可以更深入地了解市场动态。
目标公司
Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.
These are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a cerebrospinal fluid (CSF) leak. Biological dura substitutes and synthetic dura substitutes are tracked under this segment.
Dural tears are a risk in craniotomy and spinal fusion surgeries. Inadequate repair can lead to cerebrospinal fluid leakage, infection, and neurological deficits. Small tears are closed watertight, while larger ones require dura substitutes. Dura substitutes are more commonly used in craniotomy procedures than in spinal interventions.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Dura Substitutes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Integra LifeSciences Corp, B. Braun Melsungen AG, Medtronic Plc, DePuy Synthes Inc, Regenity Biosciences, Baxter International Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -